Point72 Hong Kong LTD Fusion Pharmaceuticals Inc. Call Options Transaction History
Point72 Hong Kong LTD
- $1.57 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FUSN
# of Institutions
5Shares Held
93KCall Options Held
1.4KPut Options Held
0About Fusion Pharmaceuticals Inc.
- Ticker FUSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,390,500
- Description
- Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...